Novo Nordisk A/S buy melinda
Start price
08.06.23
/
10%
€147.92
Target price
08.06.24
€170.00
Performance (%)
26.29%
Price
12.09.23
€185.00
Summary
This prediction is currently active. The BUY prediction by melinda currently has a performance of 26.29%. Dividends of €1.82 are taken into consideration when calculating the performance. This prediction currently runs until 08.06.24. The prediction end date can be changed by melinda at any time. melinda has 10% into this prediction This prediction was marked as speculative and is excluded from melinda's performance statistics.Novo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S | - | - |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |